Kuppuswamy Jagarlamudi, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1000 Health Center Dr, Mattoon, IL 61938 Phone: 217-258-2250 Fax: 217-258-2249 |
Edward Crew Hoppin, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1000 Health Center Dr, Oncology Department, Mattoon, IL 61938 Phone: 217-258-2250 |
Dr. Abdur R. Shakir, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1000 Health Center Dr, Mattoon, IL 61938 Phone: 217-258-2250 Fax: 217-258-2249 |
John David Schmale, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1000 Health Center Drive, Mattoon, IL 61938 Phone: 217-258-2250 Fax: 217-258-2249 |
News Archive
Selecta Biosciences, Inc., a biopharmaceutical company developing an entirely new class of targeted vaccines and immunotherapies, today announced that Science Applications International Corporation (SAIC) has awarded Selecta a subcontract to develop a targeted synthetic vaccine particle product for malaria.
The possible mechanisms that result in dexamethasone being an effective drug against severe SARS-CoV-2 infection are investigated in a new study. The paper's authors advance the hypothesis that SARS-CoV-2 infection induces cell-specific insensitivity to glucocorticoids, possibly as an unintentional result of the viral replication cycle.
A recent survey of National Community Pharmacists Association member pharmacies utilizing NCPA's Simplify My Meds (SMM) program documented how both patients and pharmacists benefit from medication synchronization programs, or "med sync."
Physicians targeting lung tumors for radiation therapy can substantially improve their aim by combining data from two scanning techniques, according to Washington University researchers at Siteman Cancer Center and Barnes-Jewish Hospital in St. Louis.
According to the findings of a new study, by giving B vitamins to heart attack survivors their risk of having another attack is not reduced, and it may in fact do more harm than good.
› Verified 5 days ago